Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cooray Neuroconsulting AB
AB
Active
Org 5594540709
Stenkullavägen 2, 112 65
Stockholm
Medical specialists activities
· NACE 8622
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Cooray Neuroconsulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
1 075
1 121
Staff expenses
−24
−32
EBITDA
913
786
Depreciation & amort.
—
—
EBIT
913
786
Net financials
1
6
Profit before tax
913
792
Tax
−189
−166
Net profit
725
626
Balance sheet
SEK thousands
Item
2024
2025
Total assets
1 044
1 339
Equity
750
975
Long-term debt
—
—
Short-term debt
294
364
Total debt
294
364
Financial ratios
5-year trend
EBITDA margin
70.2%
This company
15.8%
Market median
+344% vs market
2024
2025
Equity ratio
72.8%
This company
38.2%
Market median
+91% vs market
2024
2025
Return on equity
64.1%
This company
18.4%
Market median
+248% vs market
2024
2025
Net profit margin
55.8%
This company
8.1%
Market median
+589% vs market
2024
2025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
2024
2025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-25 – 2024-12-31
View
PDF
More on Cooray Neuroconsulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
